| Financial Year |
March 31 2023 |
| Monetary Funds |
2,144,602,184.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,395.00 |
| Accounts Receivable |
178,687,581.84 |
| Advances to Suppliers |
16,011,068.38 |
| Other Receivables |
4,595,775.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
487,312,733.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,471,736.47 |
| Total Current Assets |
2,841,688,475.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,421,488.13 |
| Fixed Assetes |
1,085,095,471.91 |
| Under-construction Projects |
7,236,401.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,223,006.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
24,878,877.76 |
| Deferred Income Tax Assets |
8,585,933.03 |
| Other Non-Current Assets |
20,242,470.60 |
| Sub-Total of Non-Current Assets |
1,281,588,024.02 |
| Total Assets |
4,123,276,499.74 |
| Short-Term Loans |
344,684,258.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
166,032,010.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,625,317.95 |
| Taxes Payable |
30,656,380.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
133,096,539.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,989,105.83 |
| Other Current Liabilities |
2,159,334.78 |
| Sub-Total of Current Liabilities |
756,031,628.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
73,348,621.24 |
| Total Liabilities |
829,380,249.40 |
| Paid-In Capital(Or Share Stock) |
427,976,616.00 |
| Capital Surplus |
1,267,353,857.03 |
| Surplus Reserve |
219,733,555.74 |
| LESS:Treasury Stock |
59,862,606.45 |
| Undistributed Profits |
1,436,006,484.87 |
| Minority Stockholder's Interest |
2,549,805.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,291,346,445.01 |
| Owner's Equity（Stockholder's Equity） |
3,293,896,250.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,123,276,499.74 |
